Five patients with fungal meningitis whose therapy had involved intraventricular amphotericin B delivered through an Ommaya reservoir developed chemical arachnoiditis in reaction to the amphotericin B, and staphylococcal colonization of the reservoir. The arachnoiditis was successfully treated by reducing dosage of amphotericin B, and the contamination of the reservoir by its replacement.
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I
NTRAVENTRICULAR administration of amphotericin B through an Ommaya reservoir is a valuable alternative to the lumbar or cisternal route in the treatment of fungal meningitis. 8,4 However, two complications can occur: a chemical cerebral arachnoiditis TM and the contamination of the reservoir with skin bacteria, g,* This report described our experiences with these complications in five patients treated at Wilford Hall USAF Medical Center.
Case Reports

Case 1
A 13-year-old Japanese-American girl with coccidioidal meningitis developed basilar arachnoiditis and hydrocephalus for which she was given amphotericin B through an Ommaya reservoir placed in the right parietal region. In the 16th month of treatment, on August 18, 1967, after receiving 0.5 mg of intraventricular amphotericin B premixed with hydrocortisone hemisuccinate 4 and diluted in her own cerebrospinal fluid (CSF), she developed a fever of 103~ headache, nausea, and inappropriate behavior. Changes in the ventricular CSF (Table 1 ) were interpreted as due to acute bacterial meningitis, and parenteral cephalothin and gentamicin were begun. The patient improved clinically, but CSF cultures were sterile. On August 24, after a routine dose of amphotericin B, the patient again developed the same symptoms, although they were less severe than in the first episode. In retrospect the patient and her mother remembered many similar episodes following past intraventricular treatments. The reduction of amphotericin B dosage to 0.25 mg was accompanied by improved tolerance.
Three months later, on November 28, she developed the same symptoms after a routine dose of amphotericin B. The ventricular CSF culture grew a coagulasenegative staphylococcus sensitive to penicillin. Intraventricular amphotericin B was discontinued. After 3 weeks of parenteral penicillin, CSF cultures remained positive, and the Ommaya reservoir was removed. The bone surrounding the Ommaya reservoir appeared grossly infected, but microscopically only periostitis was present.
Cultures of the bone chips and Ommaya reservoir failed to grow any bacteria. The patient subsequently did well.
Case 2
A 13-year-old Negro boy who had had coccidioidal meningitis and an Ommaya reservoir in the right parietal area experienced frequent post-amphotericin episodes of headache and stiff neck. In his third treatment month the dosage was temporarily decreased from 0.5 to 0.25 mg, which was better tolerated. When the dose was again increased to 0.5 mg, he experienced an episode of headache, stiff neck, and fever of 101.8 ~ and the ventricular fluid was grossly bloody (Table 1) . He rapidly improved without specific therapy; however, coagulasenegative staphylococcus was cultured from the CSF. Intraventricular amphotericin B was temporarily discontinued; he received no antibiotics. Within 2 weeks the deeply xanthochromic CSF was so thick that it could not be aspirated from the clotted reservoir even with irrigation. The reservoir was replaced at the same site; there was no detectable evidence of infection in any tissue, but the culture of the reservoir contained the same organisms as the CSF. Antibiotics were not administered. One month after replacement of the reservoir, ventricular amphotericin B was resumed and an acute febrile meningeal reaction recurred. It was discovered that the dose had been inadvertently miscalculated and that the patient had actually received 2.5 mg of amphotericin. On a regimen of 0.125 mg per dose, the patient did well.
His family was instructed in aseptic intrathecal therapy and administered it at home. On September 17, within 24 hours of a routine intrathecal dose at home, the patient developed stiff neck, headache, and a fever of 101 ~ CSF culture grew coagulasenegative staphylococcus. Intraventricular amphotericin B was discontinued. There was rapid clinical improvement without antibiotic therapy, but repeated CSF cultures were positive. Therefore the reservoir was removed and not replaced. Cases 3, 4, 5 Three additional patients with fungal meningitis were also treated with intraventricular amphotericin B administered through Ommaya reservoirs during this period. One patient who had coccidioidal meningitis initially tolerated therapy for 11 months with only minor episodes of acute arachnoiditis after intraventricular injections; subsequently the reservoir had to be replaced three times in a 6-month period, twice due to colonization by coagulase-negative staphylococci and once because of obstruction by clot. Actual infection of tissue surrounding the colonized Ommaya reservoir was never observed. In one instance of a colonized reservoir, repeated ventricular CSF cultures grew coagulase-negative staphylococci, while simultaneous lumbar CSF cultures were sterile. The two additional patients with fungal meningitis only had occasional episodes of acute arachnoiditis following instillation of amphotericin B.
Discussion
Chemical arachnoiditis and colonization by skin bacteria are potentially preventable complications of Ommaya reservoir administration of amphotericin B. Cerebral arachnoiditis can occur even when the amphotericin B has been diluted in the patient's CSF and premixed with 20 mg of hydrocortisone hemisuccinate. Optimal therapy of fungal meningitis requires effective intrathecal levels of amphotericin, attained by 0.5 mg per dose, but individual doses of the drug may have to be less because of this arachnoiditis. 1,4 Dilution of amphotericin in ever larger volumes of CSF and mixture with larger quantities of hydrocortisone hemisuccinate may increase the tolerance. 4 Bacterial colonization of the Ommaya reservoir is a priori evidence of septic technique. It may be recognized by appropriate gram stains and cultures during an episode of chemical arachnoiditis. Clinical resolution of the arachnoiditis may occur without antibiotics even though colonization persists. Initial differentiation of Ommaya reservoir colonization from bacterial menin-gitis may be difficult because of pre-existing CSF abnormalities related to the underlying disease, or to the clinical similarity of amphotericin arachnoiditis and bacterial meningitis. The differentiation may be suggested by the history and confirmed when the arachnoiditis rapidly clears without antibiotics. Bacterial meningitis did not occur in our patients, but this must be considered a definite possibilityY -~ Colonization may be prevented by scrupulous atraumatic aseptic technique. The scalp should be shaved just before the procedure; a depilatory may eliminate small skin wounds and reduce the risk of skin infection. The scalp should be cleansed with a bactericidal antiseptic such as povidoneiodide. When colonization does occur, the reservoir should be removed. 1
